Trust Company’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$180K Buy
7,476
+953
+15% +$23K 0.02% 182
2026
Q2
$158K Sell
6,523
-415
-6% -$10K 0.01% 187
2026
Q1
$168K Buy
6,938
+24
+0.3% +$583 0.02% 188
2025
Q4
$168K Sell
6,914
-1,394
-17% -$33.9K 0.02% 187
2025
Q3
$202K Hold
8,308
– – 0.02% 142
2025
Q2
$202K Sell
8,308
-1
-0% -$24 0.02% 144
2025
Q1
$201K Buy
8,309
+1,043
+14% +$25.1K 0.02% 146
2024
Q4
$174K Buy
7,266
+5,170
+247% +$124K 0.02% 146
2024
Q3
$51.1K Hold
2,096
– – 0.01% 198
2024
Q2
$49.7K Hold
2,096
– – 0.01% 186
2024
Q1
$49.9K Buy
+2,096
New +$49.9K 0.01% 182

Other funds holding IBDS

Trust Company's IBDS Position: Q3 2026 in Review

Trust Company increased its iShares iBonds Dec 2027 Term Corporate ETF (IBDS) stake by 15% in Q3 2026, buying an estimated $23K and bringing the position to 7,476 shares worth $180K. The position accounts for 0.02% of the portfolio, ranked #182.

Trust Company first reported a position in IBDS in Q1 2024 and has held it in 11 quarters since. The position peaked at $202K in Q3 2025. 308 funds tracked by Wall St. Rank hold IBDS as of Q3 2026.

  • Trust Company held 7,476 shares of iShares iBonds Dec 2027 Term Corporate ETF worth $180K as of Q3 2026.
  • Trust Company bought 953 iShares iBonds Dec 2027 Term Corporate ETF shares in Q3 2026, an estimated $23K.
  • iShares iBonds Dec 2027 Term Corporate ETF made up 0.02% of Trust Company's portfolio in Q3 2026, its #182 holding.
  • Trust Company first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q1 2024 and has held it in 11 quarters since.
  • Trust Company's iShares iBonds Dec 2027 Term Corporate ETF position peaked at $202K in Q3 2025.
  • 308 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q3 2026.

Based on Trust Company's 13F filing for Q3 2026, filed 9 Oct 2026.